See more : Calliditas Therapeutics AB (publ) (CLTEF) Income Statement Analysis – Financial Results
Complete financial analysis of NH Prime REIT Co., Ltd. (338100.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NH Prime REIT Co., Ltd., a leading company in the REIT – Diversified industry within the Real Estate sector.
You may be interested
- Spyglass Resources Corp. (SGLRF) Income Statement Analysis – Financial Results
- Cartesian Therapeutics, Inc. (RNAC) Income Statement Analysis – Financial Results
- Onward Technologies Limited (ONWARDTEC.BO) Income Statement Analysis – Financial Results
- Rallye SA (RLYNF) Income Statement Analysis – Financial Results
- Skandinaviska Enskilda Banken AB (publ) (SEBC.F) Income Statement Analysis – Financial Results
NH Prime REIT Co., Ltd. (338100.KS)
About NH Prime REIT Co., Ltd.
NH Prime REIT is engaged in real estate leasing and supply.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 3.57B | 14.63B | 7.63B | 2.17B | 2.86B | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 439.78M | 434.69M | 130.37M | 1.56B |
| Gross Profit | 3.57B | 14.63B | 7.19B | 1.74B | 2.72B | -1.56B |
| Gross Profit Ratio | 100.00% | 100.00% | 94.24% | 80.01% | 95.43% | 0.00% |
| Research & Development | 0.00 | 0.00 | 2.03 | 1.13 | 1.08 | 0.00 |
| General & Administrative | 337.00K | 81.00K | 1.69M | 747.52M | 8.07M | 117.60K |
| Selling & Marketing | 361.07M | 1.62B | 253.28M | 266.89M | 99.19M | 0.00 |
| SG&A | 361.41M | 1.62B | 254.97M | 1.01B | 107.26M | 117.60K |
| Other Expenses | 44.11M | 167.69M | 32.01M | 20.98M | 18.45M | 22.96M |
| Operating Expenses | 405.52M | 1.78B | 286.98M | 1.04B | 125.71M | 136.99M |
| Cost & Expenses | 405.52M | 1.78B | 286.98M | 1.04B | 125.71M | 1.69B |
| Interest Income | 223.23M | 44.47M | 6.76M | 5.35M | 2.59M | 22.96M |
| Interest Expense | 90.00 | -160.00 | 6.76M | 4.70M | 0.00 | 0.00 |
| Depreciation & Amortization | 410.00 | 220.00 | -4.89B | -670.29M | -374.76M | 1.69B |
| EBITDA | 3.16B | 12.85B | 7.35B | 1.14B | 5.22B | -1.69B |
| EBITDA Ratio | 88.64% | 87.81% | 96.24% | 52.39% | 95.60% | 0.00% |
| Operating Income | 3.16B | 12.85B | 7.35B | 1.14B | 2.73B | -1.69B |
| Operating Income Ratio | 88.64% | 87.81% | 96.24% | 52.39% | 95.60% | 0.00% |
| Total Other Income/Expenses | 223.71M | 2.57B | 6.76M | 4.70M | 2.50B | 22.96M |
| Income Before Tax | 3.39B | 15.42B | 7.35B | 1.14B | 2.73B | -1.67B |
| Income Before Tax Ratio | 94.91% | 105.40% | 96.33% | 52.60% | 95.69% | 0.00% |
| Income Tax Expense | 0.00 | 113.08M | -13.52M | 1.04M | 172.51K | -1.69B |
| Net Income | 3.39B | 12.78B | 7.35B | 1.14B | 2.73B | -1.67B |
| Net Income Ratio | 94.91% | 87.35% | 96.33% | 52.56% | 95.68% | 0.00% |
| EPS | 182.00 | 684.90 | 518.32 | 315.15 | 280.37 | -89.59 |
| EPS Diluted | 182.00 | 684.90 | 518.32 | 315.15 | 280.37 | -89.59 |
| Weighted Avg Shares Out | 18.61M | 18.66M | 18.66M | 18.66M | 18.66M | 18.66M |
| Weighted Avg Shares Out (Dil) | 18.61M | 18.66M | 18.66M | 18.66M | 18.66M | 18.66M |
No news found for: 338100.KS
Source: https://incomestatements.info
Category: Stock Reports